4
Changes in Ownership
Krystal Biotech, Inc. Filed Acc 0001801385-25-000002
Chief Accounting Officer sold 750 shares at $175.22 ($131,415)
- Chief Accounting Officer gave up 8,054 shares (to pay taxes)
- Chief Accounting Officer acquired 12,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROMANO KATHRYN · Chief Accounting Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −2,268 | $176.39 | $400,053 | 13,354 | D |
| 2025-02-27 | Sale : show line 2 in the form 10b5-1 | −750 | $175.22 | $131,415 | 12,604 | D |
| 2025-02-28 | Exercise or conversion : show line 3 in the form 10b5-1 | +5,000 | 17,604 | D | ||
| 2025-02-28 | Shares withheld for taxes : show line 4 in the form 10b5-1 | −2,315 | $179.25 | $414,964 | 15,289 | D |
| 2025-02-28 | Exercise or conversion : show line 5 in the form 10b5-1 | +7,500 | 22,789 | D | ||
| 2025-02-28 | Shares withheld for taxes : show line 6 in the form 10b5-1 | −3,471 | $179.25 | $622,177 | 19,318 | D |
| Open-market sales · 750 sh · avg $175.22 · $131,415 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-28 | Exercise or conversion : show line 7 in the form 10b5-1 Performance Stock Units | −5,000 | 0 | D |
| 2025-02-28 | Exercise or conversion : show line 8 in the form 10b5-1 Performance Stock Units | −7,500 | 7,500 | D |
| 2025-02-28 | Grant or award : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | +10,000 | 10,000 | D |
| 2025-02-28 | Grant or award : show line 10 in the form 10b5-1 Restricted Stock Units | +2,200 | 2,200 | D |
Loading xslF345X05/wk-form4_1740787298.xml…